Smega Pharmaceuticals Private Limited

Pharmaceutical company manufacturing and supplying medicines and drugs, including antibiotics, diabetic and cardiovascular ranges, and medical devices.

2011 | Thane, Maharashtra (India) | Active
Last Updated:

Smega Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.14 M
  • Company Age 13 Year, 3 Months
  • Last Filing with ROC 31 Mar 2019
  • Open Charges ₹ 4.00 M
  • Revenue Growth -41.23%
  • Profit Growth -21120.74%
  • Ebitda -596.39%
  • Net Worth -19.94%
  • Total Assets 48.83%

About Smega Pharmaceuticals

Smega Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 2011 and has a history of 13 years and three months. Its registered office is in Thane, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.14 M.

The company currently has active open charges totaling ₹4.00 M.

Gautam Das, Madhav Tulsiram, and Nilesh Gajmal serve as directors at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U51909MH2011PTC223917

  • Company No.

    223917

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    14 Nov 2011

  • Date of AGM

    27 Sep 2019

  • Date of Balance Sheet

    31 Mar 2019

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Smega Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Gautam Das Country flag representing In Director 14-Nov-2011Current
Madhav Tulsiram Country flag representing In Director 10-Jan-2017Current
Nilesh Gajmal Country flag representing In Director 27-Dec-2016Current

Financial Performance of Smega Pharmaceuticals.

Smega Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 41.23% decrease. The company also saw a substantial fall in profitability, with a 21120.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.94%.

Smega Pharmaceuticals revenue growth over time
Smega Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-41.23%
Revenue from Operations
-38.63%
Total Assets
48.83%
Profit or Loss
-21120.74%
Net Worth
-19.94%
EBITDA
-596.39%

What is the Ownership and Shareholding Structure of Smega Pharmaceuticals?

In 2019, Smega Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹4.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • State Bank Of Hyderabad : 0.40 Cr

Latest Charge Details

DateLenderAmountStatus
20 Jan 2015State Bank Of Hyderabad₹4.00 MOpen

How Many Employees Work at Smega Pharmaceuticals?

Unlock and access historical data on people associated with Smega Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Smega Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Smega Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smega Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Smega Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Smega Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2019 as per latest MCA records.

  • Balance Sheet

    Smega Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai.

  • Director Appointment

    Madhav Gaikwad Tulsiram was appointed as a Director was appointed as a Director on 10 Jan 2017 & has been associated with this company since 8 years 1 month .

  • Director Appointment

    Nilesh Laxman Gajmal was appointed as a Director was appointed as a Director on 27 Dec 2016 & has been associated with this company since 8 years 2 months .

  • Charges

    A charge with State Bank Of Hyderabad amounted to Rs. 4.00 M with Charge ID 10549124 was registered on 20 Jan 2015.

  • Director Appointment

    Gautam Kumar Aniruddha Das was appointed as a Director was appointed as a Director on 14 Nov 2011 & has been associated with this company since 13 years 3 months .

Frequently asked questions

  • What is the Incorporation or founding date of Smega Pharmaceuticals Private Limited?

    Smega Pharmaceuticals Private Limited was incorporated on 14 Nov 2011.

  • What is authorized share capital and paid-up capital of Smega Pharmaceuticals Private Limited?

    The authorized share capital of Smega Pharmaceuticals Private Limited is ₹ 0.20 M and paid-up capital is ₹ 0.14 M.

  • Who are the current board members & directors of Smega Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Smega Pharmaceuticals Private Limited.

    • Gautam Kumar Aniruddha Das
    • Madhav Gaikwad Tulsiram
    • Nilesh Laxman Gajmal

  • What is the registered address of Smega Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Smega Pharmaceuticals Private Limited is Office No.607 6Th Floor A-Wing Hermes Antrium Plot No.57 Sec-11, India, Belapur, Maharashtra, 400614.

  • What is the corporate identification number (CIN) and company number of Smega Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Smega Pharmaceuticals Private Limited is U51909MH2011PTC223917 and the company number is 223917 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Smega Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2019, the revenue trend for Smega Pharmaceuticals Private Limited has fallen by -41.23%.

  • What change has been observed in the net worth of Smega Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2019 indicates that The net worth of Smega Pharmaceuticals Private Limited has experienced an downturn of -19.94%.

  • What are the total open charges for Smega Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2019, The total open charges for Smega Pharmaceuticals Private Limited amount to ₹ 4.00 M.

  • When was the last Balance Sheet of Smega Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Smega Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2019.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors